Dyne Therapeutics, Inc.(DYN)

Biotechnology · Waltham, MA

$15.44+0.24 (+1.58%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

EV/EBIT Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBIT ratio is N/A as of 2026-10-06T11:31:46.002Z.

Stored calculation inputs

Calculation as of: 2026-10-06T11:31:46.002Z.

Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 2,883,358,240
Total debt · period ending 2026-06-30: 19,871,000
Cash · period ending 2026-06-30: 676,114,000
TTM operating income · period ending 2026-06-30: -536,958,000

FMP input reference: e7bb4fe4bb3aa983eb4620adc8aa5d0f555a5020ff21ce65ee2b72f9631e0f85

EV/EBITDA|EV/Sales|Operating Income|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

DYN EV/EBIT Ratio Metrics

EV/EBIT RATIO

N/A

DYN Competitors' EV/EBIT Ratio

DYN

Dyne Therapeutics, Inc.

Current

Market Cap

$2.88B

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TMDX

TransMedics Group, Inc.

vs DYN

Market Cap

$2.87B

EV/EBIT Ratio

39.99x

TTM Avg

46.98x

3Y Avg

64.49x

5Y Avg

64.49x

ATRC

AtriCure, Inc.

vs DYN

Market Cap

$2.87B

EV/EBIT Ratio

199.47x

TTM Avg

169.00x

3Y Avg

169.00x

5Y Avg

169.00x

AVAH

Aveanna Healthcare Holdings Inc.

vs DYN

Market Cap

$2.69B

EV/EBIT Ratio

14.17x

TTM Avg

12.70x

3Y Avg

46.55x

5Y Avg

42.04x

ACHC

Acadia Healthcare Company, Inc.

vs DYN

Market Cap

$2.69B

EV/EBIT Ratio

15.00x

TTM Avg

12.41x

3Y Avg

11.52x

5Y Avg

10.90x

AMLX

Amylyx Pharmaceuticals, Inc.

vs DYN

Market Cap

$3.09B

EV/EBIT Ratio

N/A

TTM Avg

9.47x

3Y Avg

9.47x

5Y Avg

9.47x

ALMR

Alamar Biosciences, Inc.

vs DYN

Market Cap

$2.64B

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BEAM

Beam Therapeutics Inc.

vs DYN

Market Cap

$2.64B

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ARQT

Arcutis Biotherapeutics, Inc.

vs DYN

Market Cap

$3.15B

EV/EBIT Ratio

94.18x

TTM Avg

650.30x

3Y Avg

650.30x

5Y Avg

650.30x

DNLI

Denali Therapeutics Inc.

vs DYN

Market Cap

$3.16B

EV/EBIT Ratio

N/A

TTM Avg

142.94x

3Y Avg

142.94x

5Y Avg

142.94x

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
Dyne Therapeutics, Inc. (DYN)	$2.88B	N/A	N/A	N/A	N/A
TransMedics Group, Inc. (TMDX)vs ›	$2.87B	39.99x	46.98x	64.49x	64.49x
AtriCure, Inc. (ATRC)vs ›	$2.87B	199.47x	169.00x	169.00x	169.00x
Aveanna Healthcare Holdings Inc. (AVAH)vs ›	$2.69B	14.17x	12.70x	46.55x	42.04x
Acadia Healthcare Company, Inc. (ACHC)vs ›	$2.69B	15.00x	12.41x	11.52x	10.90x
Amylyx Pharmaceuticals, Inc. (AMLX)vs ›	$3.09B	N/A	9.47x	9.47x	9.47x
Alamar Biosciences, Inc. (ALMR)vs ›	$2.64B	N/A	N/A	N/A	N/A
Beam Therapeutics Inc. (BEAM)vs ›	$2.64B	N/A	N/A	N/A	N/A
Arcutis Biotherapeutics, Inc. (ARQT)vs ›	$3.15B	94.18x	650.30x	650.30x	650.30x
Denali Therapeutics Inc. (DNLI)vs ›	$3.16B	N/A	142.94x	142.94x	142.94x